Small-Molecule APIs

Jan 27, 2016
PharmTech Multimedia
By Pharmaceutical Technology Editors
Andrew Badrot, founder and CEO of Centroflora CMS, discussed the acquisition and technical transfer of Boehringer Ingelheim’s (BI) non-captive phytochemical API portfolio with Pharmaceutical Technology.
Jan 14, 2016
By Pharmaceutical Technology Editors
FDA issued a warning letter to Zhejiang Hisun Pharmaceutical Co., Ltd., as a result of inspections that took place on March 2–7, 2015 at the Taizhou City, Zhejiang Province, API manufacturing facility.
Jan 02, 2016
Pharmaceutical Technology
FDA approved 45 novel new drugs in 2015, the highest number of approvals since 1996 and second-highest ever.
Jan 02, 2016
Pharmaceutical Technology
Nanoscale catalysts and engineered nanoparticles may have a big impact on small-molecule pharmaceuticals.
Dec 30, 2015
PTSM: Pharmaceutical Technology Sourcing and Management
By Pharmaceutical Technology Editors
BASF and Sumitomo Chemical explore in vitro system for chemical safety evaluation.
Dec 02, 2015
Pharmaceutical Technology
A strong API market is expected in 2016 despite fewer new drug approvals.
Nov 30, 2015
PTSM: Pharmaceutical Technology Sourcing and Management
By Pharmaceutical Technology Editors
The ReactoMate Datum controlled lab reactor system accommodates a range of vessel sizes.
Nov 26, 2015
PTSM: Pharmaceutical Technology Sourcing and Management
By Pharmaceutical Technology Editors
Ash Stevens has received FDA’s approval to manufacture Takeda’s multiple myeloma drug, ixazomib, at its facility in Riverview, Michigan.
Nov 05, 2015
PTSM: Pharmaceutical Technology Sourcing and Management
By Pharmaceutical Technology Editors
BASF’s new multi-product amines plant in Ludwigshafen, Germany meets growing demand for amines in various applications, including pharmaceuticals.
Nov 02, 2015
Pharmaceutical Technology
Efficient syntheses are possible using multi-component and cross-dehydrogenative, heteroaromatic C-H silylation reactions.
native1_300x100
lorem ipsum